Journal of Antivirals & Antiretrovirals : Citations & Metrics Report
Articles published in Journal of Antivirals & Antiretrovirals have been cited by esteemed scholars and scientists all around the world. Journal of Antivirals & Antiretrovirals has got h-index 22, which means every article in Journal of Antivirals & Antiretrovirals has got 22 average citations.
Following are the list of articles that have cited the articles published in Journal of Antivirals & Antiretrovirals.
| Journal total citations count | 2004 |
| Journal impact factor | 5.32 |
| Journal 5 years impact factor | 5.62 |
| Journal cite score | 5.3 |
| Journal h-index | 22 |
| Journal h-index since 2019 | 17 |
Important citations (1101)
naga anusha p (2011) antiretroviral strategies for treatment of hiv. j antivir antiretrovir 1: 2. |
|
hima bindu a, naga anusha p (2011) adverse effects of highly active anti-retroviral therapy (haart). j antivir antiretrovir 3: 060-064. |
|
mtambo a, chan k, shen a, lima v, hogg r, et al. (2012) treatment limitations imposed by antiretroviral drug resistance mutations: implication for choices of first line regimens in resourceâ€limited settings. hiv medicine. 13: 141-147. |
|
ngum nh, ngum an, jini ss (2015) opportunistic intestinal protozoan infections in hiv/aids patients on antiretroviral therapy in the north west region of cameroon. british microbiology research journal 7: 269-275. |
|
singh dd, singh v (2015) prevalence of intestinal parasitic infections in hiv infected patients presenting with diarrhea and their association with cd4+ counts. international journal of applied sciences and biotechnology 3: 96-100. |
|
aryee en (2012) intestinal parasitic infection in hiv-infected patients at different cd4 t-cell counts in an african rural and peri-urban setting (doctoral dissertation). |
|
soumya d, hima bindu a (2011) opportunistic diseases as a consequence of hiv/aids. j aids clin res 2: 5. |
|
naga anusha p (2011) antiretroviral strategies for treatment of hiv. j antivir antiretrovir 1: 2. |
|
alemseged m, girma m (2015) prevalence and associated risk factors o f opportunistic intestinal parasites among hiv positive and negative individual s in south ethiopia: a case control study. baoj hiv 15: 2-7. |
|
teklemariam z, abate d, mitiku h, dessie y (2013) prevalence of intestinal parasitic infection among hiv positive persons who are naive and on antiretroviral treatment in hiwot fana specialized university hospital, eastern ethiopia. isrn aids 11: 21-25. |
|
elshabrawy ha (2010) development of instantaneous protection against sars-cov with implications for multiple rna viruses (doctoral dissertation, university of illinois at chicago). |
|
de wit e, munster vj. nipah virus emergence, transmission, pathogenesis (2015) inglobal virology i-identifying and investigating viral diseases 29: 125-146 |
|
zahoor ba, mudie li (2015) the imperative to develop a human vaccine for the hendra virus in australia. infection ecology & epidemiology 29: 5. |
|
aljofan m (2015) henipaviruses are not yet history. future virology 10: 507-515. |
|
mathieu c, horvat b (2015) henipavirus pathogenesis and antiviral approaches. expert review of anti-infective therapy. 13: 343-354. |
|
aljofan m (2013) hendra and nipah infection: emerging paramyxoviruses.virus research 177: 119-126. |
|
aguilar hc, lee b (2011) emerging paramyxoviruses: molecular mechanisms and antiviral strategies. expert reviews in molecular medicine 13: e6. |
|
mahalingam s, herrero lj, playford eg, spann k, herring b, et al. (2012) hendra virus: an emerging paramyxovirus in australia. the lancet infectious diseases. 12: 799-807. |
|
batbold u, butov do, kutsyna ga, damdinpurev n, grinishina ea. double-blind, placebo-controlled, 1: 1 randomized phase iii clinical trial of immunoxel honey lozenges as an adjunct immunotherapy in 269 patients with pulmonary tuberculosis. immunotherapy. 2017;9: 13-24. |
|
naga anusha p, siddiqui a, hima bindu a. immuno defense mechanism against tumors. j cancer sci ther. 2011;s: 17: 2. |
|